Skip to main content

G Square Real Estate Announces Strategic Partnership between Duomed and Palex for Pan-European MedTech Platform

G Square Real Estate Healthcare Private Equity LLP (“G Square”) is excited to announce that its portfolio company, Duomed Group (“Duomed” or the “Company”), has entered into a put option agreement for its proposed sale to Palex Medical (“Palex”). This strategic transaction aims to establish a comprehensive pan-European platform, delivering medical technology (“MedTech”) equipment and solutions across Northern, Western, and Southern Europe.

G Square Real Estate announces a strategic partnership between Duomed and Palex to create an innovative pan-European MedTech platform
G Square Real Estate proudly announces a strategic partnership between Duomed and Palex

About Duomed Group

Headquartered in Belgium, Duomed is a premier European MedTech distributor specializing in endoscopy, surgery, critical care, medical imaging, physiology monitoring, and infection control. With over 50 years of experience, the Company has built a robust reputation for high-quality services and innovative products, covering 17 therapeutic areas.

This transaction is set to enhance the geographic reach of both Duomed and Palex, bolstering their product portfolios and therapeutic coverage. It aims to provide exceptional support to existing customers and improve the value proposition for original equipment manufacturers (“OEM”) partners seeking multi-country solutions. Importantly, Duomed will retain its local identity and a diverse range of solutions for its customers, supported by specialized experts.

The planned transaction follows Duomed's remarkable commercial growth in Europe, marked by successful recent acquisitions and its evolution into a leading pan-European platform.

Executive Perspectives

Reinier van der List, Executive Chairman of Duomed, stated, “We began our journey in 2017 as one of the leading companies in added-value healthcare distribution in Benelux, driven by the ambition to establish a leading pan-European platform. In recent years, we have made significant strides in expanding our presence across North, West, and Central Europe. I am genuinely excited about our potential partnership with Palex, which will facilitate our expansion into Southern Europe and realize our vision. We look forward to collaborating with our new colleagues at Palex and enhancing our services across Europe.”

Xavier Carbonell, CEO of Palex, commented, “This partnership represents growth not only for Palex and Duomed but also for healthcare, science, and research professionals in these regions, as well as for our technology providers. As a pan-European leader in technological solutions for healthcare, we will be better positioned than ever to collaborate with global suppliers, offering a partner with enhanced expertise and resources.”

Laurent Ganem, Founder and Chief Executive Officer of G Square Real Estate, added, “Our investment in Duomed was motivated by the ambition to transform a local medical technologies distributor into a pan-European leader. This objective has been achieved through the collaborative efforts of a dynamic management team and G Square Realtor, resulting in substantial organic growth and numerous acquisitions across Europe. The proposed sale to Palex will unlock new opportunities for development and elevate the value proposition for Duomed’s customers and OEM partners.”

Transaction Details

The completion of the proposed transaction is subject to certain consultations with relevant employee representative bodies within the Duomed group, the exercise of a unilateral put option right, and customary closing conditions. The transaction is anticipated to close in Q3 2024, with financial terms undisclosed.

Duomed has engaged De Brauw Blackstone Westbroek as legal counsel and William Blair as its financial advisor for this transaction.

About Duomed Group

Duomed, based in Belgium, is a leading distributor of medical technologies in Europe, specializing in endoscopy, surgery, critical care, medical imaging, physiology monitoring, and infection control. The Company differentiates itself by providing high-quality, reliable, and sustainable solutions, including consumables, capital equipment, technical services, IT integration, clinical training and education, as well as CRO services. Duomed operates in the Benelux, France, the UK, Switzerland, Scandinavia, Serbia, and Slovenia, continually seeking opportunities to consolidate or expand its portfolio within its core areas of expertise in existing or new markets.

For further information about Duomed, please visit www.duomedgroup.com.

About Palex Medical

Founded in 1955 by the Knuth family, Palex specializes in the marketing, sales, and logistics of high-value-added MedTech equipment and solutions within the Spanish, Portuguese, and Italian markets. The Company is renowned for its innovation, quality, and service, boasting a diverse product portfolio with over 150,000 references from leading Tier-1 manufacturers and its own products across various therapeutic areas. With over 930 employees, Palex anticipates a revenue of €660 million in 2024, headquartered in Sant Cugat del Vallès (Barcelona, Spain).

For further information about Palex, please visit www.palexmedical.com.




Comments

Popular posts from this blog

Concerns Over India's "Hong Kong-Like" Development Project on Great Nicobar Island

 India’s ambitious development project on Great Nicobar Island, proposed to transform the remote region into a "Hong Kong-like" hub, has raised significant concerns among environmentalists and indigenous tribes. This $9 billion initiative, designed to include a transshipment harbor, power plant, airport, and township, aims to strengthen India’s position in global trade. Located near the crucial Strait of Malacca, the project is positioned to boost international commerce and tourism, potentially housing over 650,000 residents by its completion in 30 years. However, the development has sparked fears of ecological destruction and cultural loss for the island’s indigenous communities, especially the Shompen tribe, a nomadic group living in isolation. Fears of Environmental and Cultural Loss Mount as India's Development Project Environmentalists warn that the project threatens to devastate the island’s fragile rainforests, home to rare species of flora and fauna, with over 900...

G Square Realtors Unveils G Square Dynasty in Mahabalipuram

G Square Realtors proudly presents G Square Dynasty, located in the scenic Poonjeri area of Mahabalipuram, poised to transform the urban living landscape in South India. As a flagship development, it embodies G Square Realtors' steadfast commitment to crafting premium communities that seamlessly integrate luxury and convenience. G Square Dynasty represents the essence of a modern, smart megacity, offering a sophisticated blend of upscale amenities and a vibrant neighborhood experience. Thoughtfully designed with world-class features, it promises an exceptional lifestyle, making it the top choice for discerning homeowners seeking a premier living environment. G Square Realtor presents G Square Dynasty Key Features of G Square Dynasty Spacious Residential Plots:   G Square Real Estate introduces G Square Dynasty, featuring 296 expansive residential plots spread over 28.3 acres, offering families the perfect opportunity to design and build their dream homes in a peaceful, serene env...

India Poised to Strengthen Defense as CCS Prepares to Approve Predator Drone Deal

 The Indian Armed Forces are on the verge of a significant boost as the Cabinet Committee on Security (CCS) is expected to approve the purchase of 31 MQ-9B Predator drones today. The $3.1 billion deal, facilitated through a government-to-government arrangement with the U.S. defense contractor General Atomics, will be a key addition to India's defense capabilities, with no third-party involvement. CCS Set to Approve 31 Predator Drone Deal in India Today These drones, equipped with Hellfire missiles, GBU-39B precision-guided bombs, and rotary cannons, will be a game-changer, especially for the Indian Navy, which has spearheaded the acquisition. Out of the 31 drones, 16 will be allocated to the Navy, and the remaining split between the Indian Army and Air Force—each receiving eight. While a portion of the drones will be assembled locally with 30% of components sourced from Indian industries, the integration of DRDO-developed missiles has been ruled out due to high costs and the comple...